Therapy News and Research

RSS

First pelvic reconstruction surgery in cancer patient performed at Ohio State's Medical Center

In a rare and medically remarkable operation, a multi-disciplinary team of surgeons at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute removed the left leg, hip and pelvis of a cancer patient, and used the healthy, living bones from his amputated leg to completely rebuild the connection between his spine and remaining right pelvis to support a high-tech prosthetic leg.

6 May 2011

U.S. Physical Therapy first quarter net revenue increases 12.6% to $56,741,000

U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the first quarter ended March 31, 2011.

6 May 2011

FDA approves Medtronic's two new dual-electrode leads for cardiac resynchronization therapy devices

Medtronic, Inc. today announced the U.S. Food and Drug Administration approval and launch of the Attain Ability Plus and the Attain Ability Straight left-heart leads for use with cardiac resynchronization therapy devices in treating heart failure patients.

From Medtronic 6 May 2011

Short courses of antibiotics safer for children with respiratory infections on ventilators

Short courses of antibiotics appear just as effective as longer ones - and a great deal safer - in treating respiratory infections that might cause pneumonia in children on temporary breathing devices, according to a Johns Hopkins Children's Center study published online May 3 in Clinical Infectious Diseases.

6 May 2011

Bayer MaterialScience LLC’s polycarbonate gives innovative sinus therapy device strength and striking color

Anyone suffering from colds, flu, sinusitis, allergies, croup and chronic dryness knows the soothing power of warm vapor. Vapore, Inc. has brought a new dimension to this relief with its innovative, over-the-counter (OTC) sinus therapy device, MyPurMist™.

5 May 2011

Angel Medical Systems to present observations of ischemic events detected using permanently implanted intracardiac ST-segment monitor in high risk CAD patients

Angel Medical Systems has announced that David Keenan will be presenting on behalf of Mitchell Krucoff, MD, FACC, Chairman, Division of Cardiology, Duke University, Durham, NC, on May 6th, 2011 from 2:45-3:00 PM at the Heart Rhythm Society's 32nd Annual Scientific Sessions at the Moscone Center in San Francisco, California.

5 May 2011

Asthma ‘pill-a-day’ shows similar effectiveness as inhalers: Study

A new study has shown that a ‘once-a-day’ pill may be on par with an inhaler at combating asthma. This tablet, say researchers could revolutionize treatment for the condition, meaning patients are no longer reliant on inhalers, which many find difficult to use. Around 5.4 million Britons have asthma, including 1.1 million children.

5 May 2011

Short antibiotic courses effective, safer for children with breathing-tube infections

Short courses of antibiotics appear just as effective as longer ones — and a great deal safer — in treating respiratory infections that might cause pneumonia in children on temporary breathing devices, according to a Johns Hopkins Children’s Center study published online May 3 in Clinical Infectious Diseases.

5 May 2011

PhotoMedex introduces DNA Damage Control sunscreens

PhotoMedex, Inc. a leading supplier of advanced, clinical skincare and medical laser products, today introduced DNA Damage Control, the breakthrough treatment sunscreens that feature advanced photoprotection with DNA repair technology.

5 May 2011

POZEN reports revenue of $4.5 million for first quarter 2011

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2011.

5 May 2011

New test can diagnose deadly human fungal infections

Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

5 May 2011

Study demonstrates value of MicroPulse technology for diabetic macular edema treatment

IRIDEX Corporation today announced that leading clinicians have performed and published the results of a new study that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema.

5 May 2011

Over 1000 patients enrolled in world's largest ever pancreatic cancer vaccine trial

KAEL-GemVax, a leading oncology biopharmaceutical company, today announced that it had been officially notified by the independent Data Monitoring Committee that over 1000 patients have been enrolled in the TeloVac Study, making it the world's largest ever pancreatic cancer vaccine trial.

5 May 2011

Genome epigenetic analysis reveals new ways to detect and treat breast cancer

The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported.

5 May 2011

Clinical study: Celecoxib drug may treat breast cancer

The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.

5 May 2011

Research experts to speak at brain tumor educational conference

Patients, families and caregivers are invited to attend an educational conference covering many aspects of brain tumors May 14 at Cedars-Sinai Medical Center.

5 May 2011

Cantor warns that health law will lead to care rationing

The House Majority Leader expressed this concern while speaking to the College of American Pathologists.

5 May 2011

Childhood cancer survivors may face high risk of late GI complications after therapy

Patients who received therapy for cancer during childhood have an increased risk of developing gastrointestinal complications later in life, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

5 May 2011

Thomas Jefferson University receives award to develop novel radiation drugs

Shortly before Japan's devastating nuclear incident, researchers at Thomas Jefferson University and Hospitals received an award to find novel drugs to treat people exposed to dangerous amounts of radiation in the wake of a nuclear terrorist attack or a nuclear accident.

5 May 2011

Acetyl resveratrol could protect against radiation sickness

In the midst of ongoing concerns about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a substance similar to resveratrol - an antioxidant found in red wine, grapes and nuts - could protect against radiation sickness. The report appears in ACS Medicinal Chemistry Letters.

5 May 2011

Therapy News and Research

First pelvic reconstruction surgery in cancer patient performed at Ohio State's Medical Center

U.S. Physical Therapy first quarter net revenue increases 12.6% to $56,741,000

FDA approves Medtronic's two new dual-electrode leads for cardiac resynchronization therapy devices

Short courses of antibiotics safer for children with respiratory infections on ventilators

Bayer MaterialScience LLC’s polycarbonate gives innovative sinus therapy device strength and striking color

Angel Medical Systems to present observations of ischemic events detected using permanently implanted intracardiac ST-segment monitor in high risk CAD patients

Asthma ‘pill-a-day’ shows similar effectiveness as inhalers: Study

Short antibiotic courses effective, safer for children with breathing-tube infections

PhotoMedex introduces DNA Damage Control sunscreens

POZEN reports revenue of $4.5 million for first quarter 2011

New test can diagnose deadly human fungal infections

Study demonstrates value of MicroPulse technology for diabetic macular edema treatment

Over 1000 patients enrolled in world's largest ever pancreatic cancer vaccine trial

Genome epigenetic analysis reveals new ways to detect and treat breast cancer

Clinical study: Celecoxib drug may treat breast cancer

Research experts to speak at brain tumor educational conference

Cantor warns that health law will lead to care rationing

Childhood cancer survivors may face high risk of late GI complications after therapy

Thomas Jefferson University receives award to develop novel radiation drugs

Acetyl resveratrol could protect against radiation sickness

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News